![Applied Sciences | Free Full-Text | Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma Applied Sciences | Free Full-Text | Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma](https://www.mdpi.com/applsci/applsci-10-07337/article_deploy/html/images/applsci-10-07337-g002.png)
Applied Sciences | Free Full-Text | Treatment Strategy of Transarterial Chemoembolization for Hepatocellular Carcinoma
![58-year-old male with hepatocellular carcinoma treated with TACE to a... | Download Scientific Diagram 58-year-old male with hepatocellular carcinoma treated with TACE to a... | Download Scientific Diagram](https://www.researchgate.net/profile/Robert-Ryu/publication/50808408/figure/fig1/AS:340313278304264@1458148416466/58-year-old-male-with-hepatocellular-carcinoma-treated-with-TACE-to-a-SACE-level-2.png)
58-year-old male with hepatocellular carcinoma treated with TACE to a... | Download Scientific Diagram
![Best radiological response to trans‐arterial chemoembolization for hepatocellular carcinoma does not imply better outcomes - HPB Best radiological response to trans‐arterial chemoembolization for hepatocellular carcinoma does not imply better outcomes - HPB](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2041377811/2055145923/gr1.jpg)
Best radiological response to trans‐arterial chemoembolization for hepatocellular carcinoma does not imply better outcomes - HPB
![Blood supply characteristics of pedunculated hepatocellular carcinoma prior to and following transcatheter arterial chemoembolization treatment: An angiographic demonstration Blood supply characteristics of pedunculated hepatocellular carcinoma prior to and following transcatheter arterial chemoembolization treatment: An angiographic demonstration](https://www.spandidos-publications.com/article_images/ol/15/3/ol-15-03-3383-g03.jpg)
Blood supply characteristics of pedunculated hepatocellular carcinoma prior to and following transcatheter arterial chemoembolization treatment: An angiographic demonstration
![Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization - ScienceDirect Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666379121003128-fx1.jpg)
Supervised learning based on tumor imaging and biopsy transcriptomics predicts response of hepatocellular carcinoma to transarterial chemoembolization - ScienceDirect
![Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) as a Bridge to Transplant in Unresectable Hepatocellular Carcinoma | SpringerLink Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) as a Bridge to Transplant in Unresectable Hepatocellular Carcinoma | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-021-10278-6/MediaObjects/10434_2021_10278_Figa_HTML.png)
Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) as a Bridge to Transplant in Unresectable Hepatocellular Carcinoma | SpringerLink
![A 78-year-old man with HCCs treated with TACE using DSA alone. A CT... | Download Scientific Diagram A 78-year-old man with HCCs treated with TACE using DSA alone. A CT... | Download Scientific Diagram](https://www.researchgate.net/profile/Kenichiro-Okumura-2/publication/239734279/figure/fig1/AS:674136208728066@1537738005603/A-78-year-old-man-with-HCCs-treated-with-TACE-using-DSA-alone-A-CT-showed-two-tumors-in.png)
A 78-year-old man with HCCs treated with TACE using DSA alone. A CT... | Download Scientific Diagram
![Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis | World Journal of Surgical Oncology Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis | World Journal of Surgical Oncology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12957-022-02495-4/MediaObjects/12957_2022_2495_Fig1_HTML.png)
Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis | World Journal of Surgical Oncology
![Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma with Hepatic Arteriovenous Shunt after Temporary Balloon Occlusion of Hepatic Vein - Journal of Vascular and Interventional Radiology Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma with Hepatic Arteriovenous Shunt after Temporary Balloon Occlusion of Hepatic Vein - Journal of Vascular and Interventional Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5e84f7d4-3457-4c75-840d-11c1fe59c945/gr1_lrg.jpg)
Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma with Hepatic Arteriovenous Shunt after Temporary Balloon Occlusion of Hepatic Vein - Journal of Vascular and Interventional Radiology
![Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium - Shanker - 2021 - Journal of Gastroenterology and Hepatology - Wiley Online Library Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium - Shanker - 2021 - Journal of Gastroenterology and Hepatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/84df44a7-425a-4303-ba95-55552453a027/jgh15175-fig-0001-m.jpg)
Stereotactic radiotherapy for hepatocellular carcinoma: Expanding the multidisciplinary armamentarium - Shanker - 2021 - Journal of Gastroenterology and Hepatology - Wiley Online Library
![Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial - The Lancet Gastroenterology & Hepatology Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial - The Lancet Gastroenterology & Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2103153051/2080500327/gr1.gif)
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial - The Lancet Gastroenterology & Hepatology
![Transarterial chemoembolization, ablation, tyrosine kinase inhibitors, and immunotherapy (TATI): A novel treatment for patients with advanced hepatocellular carcinoma Meng M, Li W, Yang X, Huang G, Wei Z, Ni Y, Han X, Transarterial chemoembolization, ablation, tyrosine kinase inhibitors, and immunotherapy (TATI): A novel treatment for patients with advanced hepatocellular carcinoma Meng M, Li W, Yang X, Huang G, Wei Z, Ni Y, Han X,](https://www.cancerjournal.net/articles/2020/16/2/images/JCanResTher_2020_16_2_327_285177_f3.jpg)